# Lantus in Prediabetes

> **NCT00348972** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 20 (—)

## Conditions studied

- Hyperglycemia
- Diabetes Mellitus

## Interventions

- **DRUG:** Lantus® (insulin glargine)

## Key facts

- **NCT ID:** NCT00348972
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348972, "Lantus in Prediabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00348972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*